Search
To determine the efficacy of advanced hybrid closed-loop therapy in a high-risk cohort of youth on continuous subcutaneous insulin infusion with or without continuous glucose monitoring with suboptimal glycemia.
To explore parents' experiences of using continuous glucose monitoring in their young children with early-stage type 1 diabetes, being followed in the Australian Environmental Determinants of Islet Autoimmunity (ENDIA) study.
Less than 20% of Australians with type 1 diabetes (T1D) meet recommended glucose targets. Technology use is associated with better glycaemia, with the most advanced being automated insulin delivery (AID) systems, which are now recommended as gold-standard T1D care. Our Australian AID trial shows a wide spectrum of adults with T1D can achieve recommended targets. Other studies, including lived experience data, are supportive. Insulin pumps are not subsidised for most Australian adults with T1D. We advocate change.
It’s hard to believe that the DiabHQ app has been available to WA families living with T1D for over 6 months already! Since the launch in November, 2025, the DiabHQ team have been adding new features and making the app even better.
We’re looking for more community members to help with our exciting next phase of the DiabHQ mobile app
The research team at Perth Children's Hospital and the Children's Diabetes Centre are looking for participants to be involved in the new Omnipod 5 study
The Rio Tinto Children’s Diabetes Centre; a Breakthrough T1D Centre of Excellence announces $40,000 in new round of seed grants for researchers dedicated to type 1 diabetes (T1D).
The Rio Tinto Children's Diabetes Centre; a Breakthrough T1D Centre of Excellence is excited to announce that the Capacity Building Grants are now open to all staff, students and collaborators across the Centre.
This fellowship is for her research that aims to improve mental health and wellbeing outcomes for young people and their families living with type 1 diabetes (T1D).
Did you know that we now have a 'triage' section on the DiabHQ app with useful documents and a FAQs page.